Cancer stem cell-like population from non-small cell lung cancer is preferentially suppressed by EGFR-TKIs.

被引：0
|
作者：
Yang, Fan [1 ]
You, Jiacong [2 ]
Li, Yang [2 ]
Liao, Jiayu [3 ]
Zhou, Qinghua [2 ]
机构：
[1] Ctr Canc, Chengdu, Peoples R China
[2] Tianjin Med Univ, Gen Hosp, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China
[3] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-3741
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3741
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CANCER STEM CELL-LIKE POPULATION FROM NON-SMALL CELL LUNG CANCER IS PREFERENTIALLY SUPPRESSED BY EGFR-TKIS
    Zhou, Qinghua
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S465 - S465
  • [2] Cancer stem cell-like population is preferentially suppressed by EGFR-TKIs in EGFR-mutated PC-9 tumor models
    Yang, Fan
    Li, Yang
    Liu, Bin
    You, Jiacong
    Zhou, Qinghua
    EXPERIMENTAL CELL RESEARCH, 2018, 362 (01) : 195 - 202
  • [3] Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer
    Obermayr, Eva
    Koppensteiner, Nina
    Heinzl, Nicole
    Schuster, Eva
    Holzer, Barbara
    Fabikan, Hannah
    Weinlinger, Christoph
    Illini, Oliver
    Hochmair, Maximilian
    Zeillinger, Robert
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (11):
  • [4] Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib
    Hashida, Shinsuke
    Yamamoto, Hiromasa
    Shien, Kazuhiko
    Miyoshi, Yuichiro
    Ohtsuka, Tomoaki
    Suzawa, Ken
    Watanabe, Mototsugu
    Maki, Yuho
    Soh, Junichi
    Asano, Hiroaki
    Tsukuda, Kazunori
    Miyoshi, Shinichiro
    Toyooka, Shinichi
    CANCER SCIENCE, 2015, 106 (10) : 1377 - 1384
  • [5] Synergistic Roles of Curcumin in Sensitising the Cisplatin Effect on a Cancer Stem Cell-Like Population Derived from Non-Small Cell Lung Cancer Cell Lines
    Abdul Satar, Nazilah
    Ismail, Mohd Nazri
    Yahaya, Badrul Hisham
    MOLECULES, 2021, 26 (04):
  • [6] Novel TKIs in Non-Small Cell Lung Cancer
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1449 - S1449
  • [7] Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer
    Yinan Yu
    Jianguo Zhao
    Jiaona Xu
    Rui Bai
    Zewei Gu
    Xialin Chen
    Jianfang Wang
    Xueying Jin
    Gaoyang Gu
    Current Treatment Options in Oncology, 2023, 24 : 1935 - 1947
  • [8] Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer
    Yu, Yinan
    Zhao, Jianguo
    Xu, Jiaona
    Bai, Rui
    Gu, Zewei
    Chen, Xialin
    Wang, Jianfang
    Jin, Xueying
    Gu, Gaoyang
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (12) : 1889 - 1916
  • [9] Effects of entinostat onresistance to cetuximab and EGFR TKIs in non-small cell lung cancer
    Witta, Samir E.
    Chan, Dan
    Girard, Luc
    Zheng, Di
    Franekova, Veronica
    Peyton, Michael
    Zhang, Zhi-Yong
    Kline, Zoe
    Minna, John D.
    Bunn, Paul A.
    Hirsch, Fred R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Safety of EGFR-TKIs for EGFR mutation-positive non-small cell lung cancer
    Zhou, Jia-Ying
    Liu, Si-Yang
    Wu, Yi-Long
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (05) : 589 - 599
12345